80 related articles for article (PubMed ID: 8729849)
1. [Study of the reactivity of giant cell tumors of bones to different lectins].
Illés T; Dubousset J; Szendröi M
Arch Anat Cytol Pathol; 1995; 43(5-6):331-7. PubMed ID: 8729849
[TBL] [Abstract][Full Text] [Related]
2. [Lectin-histochemical characteristics of bone tumors. I. Stage-related changes in lectin-binding of giant cells in osteoclastoma].
Illés T; Jean D; Szendroi M; Fischer J
Magy Traumatol Ortop Kezseb Plasztikai Seb; 1994; 37(2):177-84. PubMed ID: 8049748
[TBL] [Abstract][Full Text] [Related]
3. Clinical, statistical and immunocytochemical characterization of giant cell tumour of bone amoung Egyptian population.
Ayoub MS; Abdel-Salam FM; Abdel-Azim AM
Egypt Dent J; 1995 Apr; 41(2):1203-9. PubMed ID: 9497657
[TBL] [Abstract][Full Text] [Related]
4. Cyclin alterations in giant cell tumor of bone.
Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of vascular endothelial growth factor in giant cell tumors of bone.
Zheng MH; Xu J; Robbins P; Pavlos N; Wysocki S; Kumta SM; Wood DJ; Papadimitriou JM
Hum Pathol; 2000 Jul; 31(7):804-12. PubMed ID: 10923916
[TBL] [Abstract][Full Text] [Related]
6. Properties of the stromal cell in giant cell tumor of bone.
Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
8. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
[TBL] [Abstract][Full Text] [Related]
9. Lysozyme and alpha 1-antitrypsin in giant-cell tumor of bone and in other lesions that contain giant cells.
Ling L; Klein MJ; Sissons HA; Steiner GC
Arch Pathol Lab Med; 1986 Aug; 110(8):713-8. PubMed ID: 3524506
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of urokinase-type plasminogen activator, its receptor, and type 2 inhibitor in giant cell tumor of bone].
Li H; Dong S; Zeng Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):386-8. PubMed ID: 11810768
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytokines on in vitro bone resorption by cells isolated from giant cell tumor of bone.
Wen J; Xie D; Yao J; Zhang M; Bi J
Chin Med J (Engl); 1999 May; 112(5):443-7. PubMed ID: 11593516
[TBL] [Abstract][Full Text] [Related]
14. CD138 (syndecan-1) expression in bone-forming tumors.
Nunez AL; Siegal GP; Reddy VV; Wei S
Am J Clin Pathol; 2012 Mar; 137(3):423-8. PubMed ID: 22338054
[TBL] [Abstract][Full Text] [Related]
15. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS
Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of giant cell tumor of bone. Histopathological analysis of 15 cases and review of the literature.
Boutou-Bredaki S; Agapios P; Papachristou G
Adv Clin Path; 2001 Jul; 5(3):71-8. PubMed ID: 11753878
[TBL] [Abstract][Full Text] [Related]
17. Relationship between binuclear and multinuclear cells in giant cell tumor of bone.
Kusuzaki K; Takeshita H; Murata H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(4):2463-7. PubMed ID: 10953311
[TBL] [Abstract][Full Text] [Related]
18. Malignancy in giant cell tumour of bone: is there a reproducible histological threshold? A study of three giant cell tumours with worrisome features.
Brimo F; Aziz M; Rosen G; Turcotte R; Nahal A
Histopathology; 2007 Dec; 51(6):864-6. PubMed ID: 18042075
[No Abstract] [Full Text] [Related]
19. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen peroxide inhibits giant cell tumor and osteoblast metabolism in vitro.
Nicholson NC; Ramp WK; Kneisl JS; Kaysinger KK
Clin Orthop Relat Res; 1998 Feb; (347):250-60. PubMed ID: 9520898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
